Dermapharm Holding Se Stock Market Value
| DMPHF Stock | 39.56 3.12 7.31% |
| Symbol | Dermapharm |
Dermapharm Holding 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dermapharm Holding's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dermapharm Holding.
| 12/21/2025 |
| 01/20/2026 |
If you would invest 0.00 in Dermapharm Holding on December 21, 2025 and sell it all today you would earn a total of 0.00 from holding Dermapharm Holding SE or generate 0.0% return on investment in Dermapharm Holding over 30 days. Dermapharm Holding is related to or competes with Sihuan Pharmaceutical, Curaleaf Holdings, Fagron NV, Almirall, CanSino Biologics, HUTCHMED, and BioArctic. More
Dermapharm Holding Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dermapharm Holding's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dermapharm Holding SE upside and downside potential and time the market with a certain degree of confidence.
Dermapharm Holding Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dermapharm Holding's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dermapharm Holding's standard deviation. In reality, there are many statistical measures that can use Dermapharm Holding historical prices to predict the future Dermapharm Holding's volatility.Dermapharm Holding Backtested Returns
We have found eight technical indicators for Dermapharm Holding SE, which you can use to evaluate the volatility of the firm. Please confirm Dermapharm Holding's Day Typical Price of 40.6, market facilitation index of 0.0066, and Rate Of Daily Change of 0.93 to check if the risk estimate we provide is consistent with the expected return of 0.0%. The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Dermapharm Holding are completely uncorrelated. Dermapharm Holding right now shows a risk of 0.0%. Please confirm Dermapharm Holding accumulation distribution and price action indicator , to decide if Dermapharm Holding will be following its price patterns.
Auto-correlation | 0.00 |
No correlation between past and present
Dermapharm Holding SE has no correlation between past and present. Overlapping area represents the amount of predictability between Dermapharm Holding time series from 21st of December 2025 to 5th of January 2026 and 5th of January 2026 to 20th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dermapharm Holding price movement. The serial correlation of 0.0 indicates that just 0.0% of current Dermapharm Holding price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Dermapharm Holding lagged returns against current returns
Autocorrelation, which is Dermapharm Holding pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Dermapharm Holding's pink sheet expected returns. We can calculate the autocorrelation of Dermapharm Holding returns to help us make a trade decision. For example, suppose you find that Dermapharm Holding has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Dermapharm Holding regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Dermapharm Holding pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Dermapharm Holding pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Dermapharm Holding pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Dermapharm Holding Lagged Returns
When evaluating Dermapharm Holding's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Dermapharm Holding pink sheet have on its future price. Dermapharm Holding autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Dermapharm Holding autocorrelation shows the relationship between Dermapharm Holding pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Dermapharm Holding SE.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Dermapharm Pink Sheet
Dermapharm Holding financial ratios help investors to determine whether Dermapharm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dermapharm with respect to the benefits of owning Dermapharm Holding security.